COCCOS transition program for teens with chronic conditions
The COCCOS Study: Implementing and Evaluating a Transition Program for Young Persons With Chronic Conditions
This program will try a co-designed transition pathway to help 17- to 18-year-olds with type 1 diabetes, asthma, or obesity move from pediatric to adult care.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 150 (estimated) |
| Ages | 16 Years to 21 Years |
| Sex | All |
| Sponsor | Universiteit Antwerpen Academic / other |
| Locations | 1 site (Ghent) |
| Trial ID | NCT07145671 on ClinicalTrials.gov |
What this trial studies
This multicenter quasi-experimental pre-test/post-test study will implement a co-designed transition program at two Belgian hospitals (Ghent University Hospital and University Hospital Antwerp) and compare it to usual care. About 150 adolescents aged 17–18 with type 1 diabetes, asthma, or obesity will be recruited, with the intervention delivered over 9–15 months and the control group followed under usual care. Outcomes include patient-reported health measures, experiences of patients and healthcare providers with implementation, and cost-effectiveness, measured at baseline, at transfer, and four months after transfer. The intervention comprises staged elements such as a transition consultation, an independent visit, and structured planning to support self-management and handover to adult services.
Who should consider this trial
Good fit: Ideal candidates are Dutch-speaking 17- to 18-year-olds with type 1 diabetes, asthma, or obesity who had at least one pediatric outpatient visit at one of the participating hospitals in the past year and plan to transfer to adult care within 12 months.
Not a fit: Patients with severe mental, cognitive, or neurological problems (who are excluded), non-Dutch speakers, those not followed at the participating hospitals, or those not transferring within the next year are unlikely to benefit from this program.
Why it matters
Potential benefit: If successful, the program could make transfers to adult care smoother, improve self-management and adherence, and reduce downstream complications and costs.
How similar studies have performed: Previous studies of structured transition programs have shown improvements in self-management and adherence for adolescents, but broad implementation and long-term evidence remain limited.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion criteria: For participants in the intervention group (IG): * 17 years old; * diagnosed with type 1 diabetes, asthma and/or obesity; * who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months; * are Dutch speaking; * planned to transfer to adult care within the next 12 months. For participants in the control group (CG): * age 17,5 and 18 years old, as the control period has a shorter duration (4 months vs. 12 months) * diagnosed with type 1 diabetes, asthma and/or obesity; * who had at least one pediatric outpatient visit, prior to inclusion, in one of both hospitals within the past 12 months; * are Dutch speaking; * planned to transfer to adult care within the next 12 months. Exclusion criteria: Applicable for both CG and IG: \- patients with severe mental, cognitive or neurological problems will be excluded
Where this trial is running
Ghent
- Ghent University Hospital — Ghent, Belgium (Recruiting)
Study contacts
- Study coordinator: Eva Goossens, Professor
- Email: eva.goossens@uantwerpen.be
- Phone: +32472722364
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.